New Leaf Biopharma Opportunities I L.P. 13D and 13G filings for Addex Therapeutics Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 4:32 pm Sale |
2022-12-31 | 13G | Addex Therapeutics Ltd ADXN |
New Leaf Biopharma Opportunities I L.P. | 115,815 3.000% |
-2,500 (-2.11%) |
Filing |
| 2022-02-18 4:54 pm Unchanged |
2022-02-11 | 13G | Addex Therapeutics Ltd ADXN |
New Leaf Biopharma Opportunities I L.P. | 118,315 6.200% |
0 (Unchanged) |
Filing |
| 2022-02-11 4:48 pm Purchase |
2021-12-31 | 13G | Addex Therapeutics Ltd ADXN |
New Leaf Biopharma Opportunities I L.P. | 118,315 4.500% |
2,500 (+2.16%) |
Filing |
| 2021-02-10 5:30 pm Purchase |
2020-12-31 | 13G | Addex Therapeutics Ltd ADXN |
New Leaf Biopharma Opportunities I L.P. | 115,815 7.100% |
115,815 (New Position) |
Filing |